New magnetically controlled thrombolytic successfully passed preclinical testing
A new anti-thrombosis drug based on magnetite nanoparticles developed at ITMO University has been successfully tested on animals. Preclinical studies showed the drug's high efficacy and lack of side effects. Clot dissolution ...